Michael J. Ruggiero is a seasoned executive in the biopharmaceutical industry with a broad range of experience in policy, advocacy, and government relations. He currently is Vice President, US Government Affairs and Policy for EMD Serono, the U.S.-based biopharmaceuticals division of Merck KGaA, of Darmstadt, Germany. He leads the function responsible for advising the company on the impact of U.S. policy on business strategy, and shaping the external policy environment to accomplish the company’s business objectives. Mr. Ruggiero sits on the U.S. Country Leadership Team and the Global Government Affairs and Policy Leadership Team.
Before joining EMD Serono, Mr. Ruggiero was Vice President, Government Strategy for Astellas Pharma US, Inc., where he led the function responsible for developing policy strategies to accomplish the company’s business objectives; designed and led the first Astellas federal policy and government affairs function; and led cross-functional/regional initiatives to address government policy at a global level.
Mr. Ruggiero previously practiced law in Washington, D.C. at the law firms of Arnold & Porter LLP and King & Spalding LLP, where he counseled and advocated on behalf of healthcare industry clients on a range of matters relating to product reimbursement and regulation.
Mr. Ruggiero is a former Vice Chair of the American Health Lawyers Association Life Sciences Practice Group, serves as adjunct faculty at the American University Washington College of Law, and is past Chairman of the Board of Directors of the National Kidney Foundation Serving the National Capital Area. He earned a J.D. cum laude from the Georgetown University Law Center and a B.A. in Economics from Syracuse University. Prior to attending law school, Mr. Ruggiero worked for the American Apparel Manufacturers Association and the American Textile Manufacturers Institute.
There are no classes currently associated with this professor.